HMGB1 and neoplasm: Tumour antigens and DAMPs such as CRT, HSP70, HSP90, and HMGB-1 are likely to be released from boiling histotripsy-treated tumour cells at the HIFU focus in situ, followed by the generations of pro-inflammatory cytokines and chemokines.